cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
04 juin 2024 16h05 HE | Cargo Therapeutics, Inc.
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
28 mai 2024 08h00 HE | Cargo Therapeutics, Inc.
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
15 avr. 2024 16h05 HE | Cargo Therapeutics, Inc.
SAN MATEO, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (Nasdaq: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell...
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
21 mars 2024 16h05 HE | Cargo Therapeutics, Inc.
CARGO Therapeutics today provided a business update and reported financial results for the quarter and year ending December 31, 2023.
22157.jpg
CAR-T Funding Report 2024: Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions
18 mars 2024 04h52 HE | Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "CAR-T Funding Report - Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions, 2024" report has been added to ...
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics to Participate in the 44th Annual Cowen Healthcare Conference
29 févr. 2024 16h01 HE | Cargo Therapeutics, Inc.
CARGO Therapeutics announced that the company will participate in the 44th Annual Cowen Healthcare Conference, taking place March 4-6, 2024, in Boston, MA.
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
03 janv. 2024 08h05 HE | Cargo Therapeutics, Inc.
SAN MATEO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell...
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results
13 déc. 2023 16h05 HE | Cargo Therapeutics, Inc.
SAN MATEO, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (Nasdaq: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell...
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Announces Scientific Advisory Board
06 déc. 2023 08h05 HE | Cargo Therapeutics, Inc.
SAN MATEO, Calif., Dec. 06, 2023 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (CRGX), a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell...
cargo-logo-full-color-rgb-1165px@300ppi.jpg
CARGO Therapeutics Announces Appointment of Ginna Laport, MD, as Chief Medical Officer
17 oct. 2023 09h05 HE | CARGO Therapeutics, Inc.
— Accomplished clinical leader with significant expertise in hematology/oncology drug development and a track record of advancing multiple modalities of cancer therapeutics — SAN MATEO, Calif., Oct. ...